Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feraheme as an MRI Contrast Agent for Pediatric Congenital Heart Disease
NCT02752191Phase 4Completed
- Start
- Apr 2016
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
A Phase 4 trial of ferumoxytol in congenital heart disease (CHD). Started Apr 2016; status: completed.
02
Drugs
ferumoxytol
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT02752191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02752191.